Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
Total | Transactions | Amount |
Buys | 4 | $21,133,729 |
Sells | 21 | $240,619,957 |
Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
12 Sep 2024 20:42 | JANX | Janux Therapeutics Inc | AVALON VENTURES XI, L.P. | 10% | 12 Sep 2024 | Sale | 161,356 | 47 | 7,583,732 | I |
12 Sep 2024 20:42 | JANX | Janux Therapeutics Inc | AVALON VENTURES XI, L.P. | 10% | 12 Sep 2024 | Sale | 30,613 | 47 | 1,438,811 | I |
12 Sep 2024 20:42 | JANX | Janux Therapeutics Inc | AVALON VENTURES XI, L.P. | 10% | 12 Sep 2024 | Sale | 158,031 | 47 | 7,427,457 | D |
12 Sep 2024 20:42 | JANX | Janux Therapeutics Inc | AVALON VENTURES XI, L.P. | 10% | 10 Sep 2024 | Sale | 6,649 | 46.66 | 310,242 | I |
12 Sep 2024 20:42 | JANX | Janux Therapeutics Inc | AVALON VENTURES XI, L.P. | 10% | 10 Sep 2024 | Sale | 35,047 | 46.66 | 1,635,293 | I |
12 Sep 2024 20:42 | JANX | Janux Therapeutics Inc | AVALON VENTURES XI, L.P. | 10% | 10 Sep 2024 | Sale | 34,326 | 46.66 | 1,601,651 | D |
12 Sep 2024 20:42 | JANX | Janux Therapeutics Inc | AVALON VENTURES XI, L.P. | 10% | 10 Sep 2024 | Sale | 11,557 | 46.13 | 533,124 | I |
12 Sep 2024 20:42 | JANX | Janux Therapeutics Inc | AVALON VENTURES XI, L.P. | 10% | 10 Sep 2024 | Sale | 2,193 | 46.13 | 101,163 | I |
12 Sep 2024 20:42 | JANX | Janux Therapeutics Inc | AVALON VENTURES XI, L.P. | 10% | 10 Sep 2024 | Sale | 11,319 | 46.13 | 522,145 | D |
10 Sep 2024 17:02 | JANX | Janux Therapeutics Inc | AVALON VENTURES XI, L.P. | 10% | 09 Sep 2024 | Sale | 2,182 | 42.33 | 92,364 | D |
10 Sep 2024 17:02 | JANX | Janux Therapeutics Inc | AVALON VENTURES XI, L.P. | 10% | 06 Sep 2024 | Sale | 20,991 | 42 | 881,622 | I |
10 Sep 2024 17:02 | JANX | Janux Therapeutics Inc | AVALON VENTURES XI, L.P. | 10% | 06 Sep 2024 | Sale | 110,644 | 42 | 4,647,048 | I |
10 Sep 2024 17:02 | JANX | Janux Therapeutics Inc | AVALON VENTURES XI, L.P. | 10% | 06 Sep 2024 | Sale | 108,365 | 42 | 4,551,330 | D |
05 Jun 2024 19:25 | JANX | Janux Therapeutics Inc | LICHTER JAY | Director , 10% | 03 Jun 2024 | Sale | 691,525 | 54.75 | 37,860,994 | I |
05 Jun 2024 19:25 | JANX | Janux Therapeutics Inc | LICHTER JAY | Director , 10% | 03 Jun 2024 | Sale | 131,196 | 54.75 | 7,182,981 | I |
05 Jun 2024 19:25 | JANX | Janux Therapeutics Inc | LICHTER JAY | Director , 10% | 03 Jun 2024 | Sale | 677,279 | 54.75 | 37,081,025 | I |
05 Jun 2024 19:19 | JANX | Janux Therapeutics Inc | AVALON VENTURES XI, L.P. | 10% | 03 Jun 2024 | Sale | 691,525 | 54.75 | 37,860,994 | I |
05 Jun 2024 19:19 | JANX | Janux Therapeutics Inc | AVALON VENTURES XI, L.P. | 10% | 03 Jun 2024 | Sale | 131,196 | 54.75 | 7,182,981 | I |
05 Jun 2024 19:19 | JANX | Janux Therapeutics Inc | AVALON VENTURES XI, L.P. | 10% | 03 Jun 2024 | Sale | 677,279 | 54.75 | 37,081,025 | D |
05 Jun 2024 19:23 | JANX | Janux Therapeutics Inc | REARDON TIGHE | Acting Chief Financial Officer | 03 Jun 2024 | Sale | 691,525 | 54.75 | 37,860,994 | I |
05 Jun 2024 19:23 | JANX | Janux Therapeutics Inc | REARDON TIGHE | Acting Chief Financial Officer | 03 Jun 2024 | Sale | 131,196 | 54.75 | 7,182,981 | I |
15 Nov 2023 16:46 | JANX | Janux Therapeutics Inc | LICHTER JAY | Director , 10% | 13 Nov 2023 | Purchase | 849,854 | 5.87 | 4,988,643 | I |
15 Nov 2023 16:48 | JANX | Janux Therapeutics Inc | REARDON TIGHE | Acting Chief Financial Officer, 10% | 13 Nov 2023 | Purchase | 849,854 | 5.87 | 4,988,643 | I |
13 Nov 2023 19:11 | JANX | Janux Therapeutics Inc | AVALON VENTURES XI, L.P. | 10% | 13 Nov 2023 | Purchase | 849,854 | 5.87 | 4,988,643 | I |
21 Jul 2023 16:31 | JANX | Janux Therapeutics Inc | RA CAPITAL MANAGEMENT, L.P. | Director , 10% | 19 Jul 2023 | Purchase | 495,008 | 12.46 | 6,167,800 | I |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)